RankingsPricing
  1. US-listed companies
  2. Novo Integrated Sciences, Inc.

Novo Integrated Sciences, Inc.NVOS

Market cap
$4.43M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Aug 31,
2017		Aug 31,
2018		Aug 31,
2019		Aug 31,
2020		Aug 31,
2021		Aug 31,
2022
Net loss-------745,264-2,117,193-403,579-4,924,209-4,470,935-33,045,178
Depreciation and amortization---------123
Fair value of vested stock options------------426,690
Common stock issued for services-----------1
Operating lease expense--------214,893541,530642,991852,580
Amortization of debt discount33,858180,461296,258--------6
Foreign currency transaction losses-----------641,643
Gain on forgiveness of debt--------377,300-21,900-
Impairment of assets-----------14
Other receivables write-off-----------299,672
Goodwill impairment-----------1
Accounts receivable------289,316263,152151,254229,015-1,103,800-457,006
Inventory-----------527,397
Prepaid expenses and other current assets------84,161-23,24491,097-61,21843,194369,647
Accounts payable325,128326,936354,98167,658-35,4306,538-412,877-331,870-140,093-275,895-45,228283,234
Accrued expenses305,506300,506301,90634,205--89,93758,328-172,309-15,591-287,03438,743
Accrued interest14,95522,38429,34118,35424,066-310,790316,22895,815114,8159,015101,353
Operating lease liability-----------618,645-806,394
Net cash used in operating activities--------934,501-822,268-441,694-1,024,802-5,884,145
Purchase of property and equipment------38,238178,626107,63512,110255,949190,168
Cash acquired with acquisition------12,249---457,489
Amounts loaned for other receivables-------38,604225,924-473,100-
Collection of other receivable-----------296,138
Net cash provided by investing activities--------217,230-842,914657,1303163,459
Receipts from (repayments to) related parties-------85,063----16,600
Repayments of notes payable------131,4546,997--311
Repayments of finance leases-----------18,435
Proceeds from issuance of convertible notes894,75011-17,914------15
Repayment of convertible notes23,00023,00066,200--------5
Proceeds from the sale of common stock, net of offering costs44472,849170,000150,000315,5643113,3997-
Proceeds from exercise of stock options45,00045,00045,000-------12,000-
Net cash (used in) provided by financing activities--------11,5743-271,6874-427,117
Effect of exchange rate changes on cash and cash equivalents---------56840,303-65,73833,328
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS--------1-15,9486-6,114,475
Interest------186,618240,366129,45995,219144,9872
Common stock issued for convertible debt-----------1
Common stock issued for acquisition----------430,8372
Warrants issued with convertible notes-----------6